FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W55851856> ?p ?o ?g. }

• W55851856 endingPage "17" @default.
• W55851856 startingPage "1" @default.
• W55851856 abstract "BACKGROUND: Diabetes mellitus is defined as a group of metabolic diseases characterized by hyperglycemia, which when untreated can lead to long-term complications, including micro- and macrovascular complications. Tight glycemic control with intensive insulin therapy has been suggested to reduce the risk of such complications in several diabetes populations; however, such an approach can also be associated with risks and challenges. There are currently several modalities available to deliver insulin and monitor glucose levels to achieve glycemic goals in diabetic patients. In July 2012, the Agency for Healthcare Research and Quality (AHRQ) published a systematic review on the comparative effectiveness of insulin delivery systems and glucose-monitoring modalities in diabetic patients receiving intensive insulin therapy. Studies from 44 publications included in the review compared the effects of continuous subcutaneous insulin infusion (CSII) with multiple daily injections (MDI) and/or real time-continuous glucose monitoring (rt-CGM) with self-monitoring of blood glucose (SMBG) among children, adolescents, or adults with either type 1 (T1DM) or type 2 diabetes (T2DM), or pregnant women with pre-existing diabetes (either T1DM or T2DM). This comparative effectiveness review evaluated which modality results in improved glycemic control, less hypoglycemia, better quality of life, and/or improved clinical outcomes. The numerous technologies and the challenges that clinicians face when determining which patient population may benefit from different insulin delivery systems and glucose-monitoring approaches motivated AHRQ to synthesize the available information to assist health professionals in making evidence-based practice decisions for their patients. The review also delineates advances in insulin delivery and glucose-monitoring systems, practical methods to achieve tight glycemic control and strategies to minimize associated risks, as well as highlights gaps in research and areas that need to be addressed in the future. OBJECTIVES: To (a) educate health care professionals on the findings from AHRQ’s 2012 comparative effectiveness review on insulin delivery and glucose-monitoring modalities in patients with diabetes; (b) apply review findings to make treatment decisions in clinical practice; and (c) identify shortcomings in the current research and future directions relating to the comparative effectiveness of insulin delivery and glucose-monitoring modalities for patients with diabetes. SUMMARY: The AHRQ systematic review of randomized clinical trials reveals that both insulin delivery modalities (CSII and MDI) demonstrate similar effectiveness on glycemic control and severe hypoglycemia in children and adolescents with T1DM and in adults with T2DM. In adults with T1DM, hemoglobin A1c decreased more with CSII than with MDI with low strength of evidence, but one study heavily influenced these results. In children and adults with T1DM, the use of CSII was associated with improved quality of life compared with MDI, with low strength of evidence, while there was insufficient strength of evidence to make conclusions regarding the quality of life for adults with T2DM. The study investigators suggest that the modality to deliver intensive insulin therapy can be individualized to patient preference in order to maximize quality of life. On all measured outcomes, there was insufficient or low strength of evidence regarding pregnant women with pre-existing diabetes.The AHRQ investigators found studies comparing the effectiveness of glucose-monitoring modalities in individuals with T1DM only. The systematic review demonstrates that rt-CGM is associated with greater lowering of A1c compared with SMBG (high strength of evidence) without affecting the risk of severe hypoglycemia (low strength of evidence) or quality of life (low strength of evidence) in nonpregnant individuals with T1DM, particularly when compliance with device use is high. Additional findings suggest that the use of sensor-augmented insulin pumps (rt-CGM + CSII) is superior to the use of MDI/SMBG use in lowering A1c in nonpregnant individuals with T1DM (moderate strength of evidence). Comparison of other outcome measures did not yield firm conclusions due to low or insufficient evidence." @default.
• W55851856 created "2016-06-24" @default.
• W55851856 creator A5008594569 @default.
• W55851856 creator A5023153504 @default.
• W55851856 date "2012-07-01" @default.
• W55851856 modified "2023-10-13" @default.
• W55851856 title "Methods for Insulin Delivery and Glucose Monitoring in Diabetes: Summary of a Comparative Effectiveness Review" @default.
• W55851856 cites W1531505795 @default.
• W55851856 cites W1586077937 @default.
• W55851856 cites W1696205784 @default.
• W55851856 cites W1752045965 @default.
• W55851856 cites W1825084674 @default.
• W55851856 cites W1909731716 @default.
• W55851856 cites W1965722550 @default.
• W55851856 cites W1966350212 @default.
• W55851856 cites W1967942822 @default.
• W55851856 cites W1968703488 @default.
• W55851856 cites W1974413439 @default.
• W55851856 cites W1976351811 @default.
• W55851856 cites W1977761436 @default.
• W55851856 cites W1981936592 @default.
• W55851856 cites W1986035507 @default.
• W55851856 cites W1987304382 @default.
• W55851856 cites W1991835641 @default.
• W55851856 cites W1995445054 @default.
• W55851856 cites W1995804697 @default.
• W55851856 cites W1996730312 @default.
• W55851856 cites W2004489444 @default.
• W55851856 cites W2012686172 @default.
• W55851856 cites W2034756707 @default.
• W55851856 cites W2036084085 @default.
• W55851856 cites W2037526159 @default.
• W55851856 cites W2045180452 @default.
• W55851856 cites W2049594784 @default.
• W55851856 cites W2063775881 @default.
• W55851856 cites W2070616275 @default.
• W55851856 cites W2076370761 @default.
• W55851856 cites W2082356347 @default.
• W55851856 cites W2082780246 @default.
• W55851856 cites W2083734050 @default.
• W55851856 cites W2097577333 @default.
• W55851856 cites W2102624023 @default.
• W55851856 cites W2104815893 @default.
• W55851856 cites W2105087056 @default.
• W55851856 cites W2105346472 @default.
• W55851856 cites W2108311162 @default.
• W55851856 cites W2111763343 @default.
• W55851856 cites W2113825239 @default.
• W55851856 cites W2114488753 @default.
• W55851856 cites W2116307911 @default.
• W55851856 cites W2125148407 @default.
• W55851856 cites W2126938133 @default.
• W55851856 cites W2131377217 @default.
• W55851856 cites W2135131610 @default.
• W55851856 cites W2136455837 @default.
• W55851856 cites W2138976255 @default.
• W55851856 cites W2142372141 @default.
• W55851856 cites W2142433802 @default.
• W55851856 cites W2144750043 @default.
• W55851856 cites W2144992094 @default.
• W55851856 cites W2147079839 @default.
• W55851856 cites W2149460395 @default.
• W55851856 cites W2152591579 @default.
• W55851856 cites W2158009484 @default.
• W55851856 cites W2159898202 @default.
• W55851856 cites W2171294019 @default.
• W55851856 cites W2187034653 @default.
• W55851856 cites W2337454357 @default.
• W55851856 cites W2397516937 @default.
• W55851856 cites W2412546007 @default.
• W55851856 cites W2769264260 @default.
• W55851856 doi "https://doi.org/10.18553/jmcp.2012.18.s6-a.1" @default.
• W55851856 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22984955" @default.
• W55851856 hasPublicationYear "2012" @default.
• W55851856 type Work @default.
• W55851856 sameAs 55851856 @default.
• W55851856 citedByCount "39" @default.
• W55851856 countsByYear W558518562013 @default.
• W55851856 countsByYear W558518562014 @default.
• W55851856 countsByYear W558518562015 @default.
• W55851856 countsByYear W558518562016 @default.
• W55851856 countsByYear W558518562017 @default.
• W55851856 countsByYear W558518562018 @default.
• W55851856 countsByYear W558518562019 @default.
• W55851856 countsByYear W558518562020 @default.
• W55851856 countsByYear W558518562021 @default.
• W55851856 crossrefType "journal-article" @default.
• W55851856 hasAuthorship W55851856A5008594569 @default.
• W55851856 hasAuthorship W55851856A5023153504 @default.
• W55851856 hasConcept C126322002 @default.
• W55851856 hasConcept C134018914 @default.
• W55851856 hasConcept C144024400 @default.
• W55851856 hasConcept C177713679 @default.
• W55851856 hasConcept C2777180221 @default.
• W55851856 hasConcept C2779306644 @default.
• W55851856 hasConcept C2779794567 @default.
• W55851856 hasConcept C2779903281 @default.
• W55851856 hasConcept C2780473172 @default.

• next